Strategic Growth CorWave is expanding manufacturing capacity and facilities in France to support ramp-up of production for its implantable LVAD technology, presenting opportunities to onboard suppliers, contract manufacturers, and regional service partners.

Clinical Progress Active engagement in presenting late-breaking results from first-in-human implants at HFSA and ongoing LVAD development signals a need for medical education partnerships, hospital adoption discussions, and key opinion leader collaboration opportunities.

Tech Advantage Proprietary wave membrane pump technology offers a differentiated value proposition over traditional LVADs, creating openings for clinical trials partnerships, reimbursement strategy discussions, and competitive positioning with peer devices.

Operations & Talent Recent leadership hires in operations and expanding HR focus indicate readiness to scale; potential sales plays include sourcing process optimization, quality and regulatory services, and large-scale manufacturing support for device production.

Financial & Partnerships Secured equity funding and active investor backing, combined with a lean revenue profile, point to partnership-heavy go-to-market approaches, including volume-based manufacturing collaborations, distributor arrangements, and contract manufacturing opportunities.